⌘K

Home/Filings/4/0001513160-11-000023

4//SEC Filing

Cataldo Tony 4

Accession 0001513160-11-000023

CIK 0001425205other

View on SEC.gov Company Profile

Filed

May 8, 8:00 PM ET

Accepted

May 9, 7:04 PM ET

Size

4.7 KB

Accession

0001513160-11-000023

Insider Transaction Report

Form 4

Period: 2011-05-06

Genesis Biopharma, IncGNBP.OB

DirectorCEO, President

Transactions

Award
Common Stock
2011-05-06$1.23/sh+3,000,000$3,690,000→ 3,000,000 total

Footnotes (1)

[F1]Shares granted as part of the Reporting Person's compensation package.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Genesis Biopharma, Inc

CIK 0001425205

Entity typeother

Related Parties

1

filerCIK 0001450565

Filing Metadata

Form type: 4
Filed: May 8, 8:00 PM ET
Accepted: May 9, 7:04 PM ET
Size: 4.7 KB

View on SEC.gov